RxDoctor Payments Data
★ My doctorsLook up a doctor →

Steven Hodgkin

Victorville, CANPI 1780675587

Payments from drug & device makers

$4,095in general payments, 2019–2025

Across 169 payments — averaging $24.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$722
  • LEO Pharma Inc.$538
  • Regeneron Healthcare Solutions, Inc.$416
  • Pfizer$373
  • Sanofi$343
  • UCB, Inc.$337
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,99698%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)39$722
LEO Pharma Inc.23$538
Regeneron Healthcare Solutions, Inc.14$416
Pfizer20$373
Sanofi6$343
UCB, Inc.15$337
Janssen Scientific Affairs, LLC2$240
Johnson & Johnson10$209
Genentech USA, Inc.3$132
Novartis6$114
Lilly USA, LLC5$107
Merck5$76
Almirall LLC2$75
Lumenis, Inc1$68
Dermira, Inc.1$52
EPI Health, LLC2$51
Ortho Dermatologics, A Division Of Bausch Health US, LLC3$48
DUSA Pharmaceuticals, Inc.2$43
Sanofi-aventis U.S. LLC2$35
Organogenesis Inc.2$33
Merz North America, Inc.1$21
Biofrontera Inc.1$14
Prugen, Inc. Pharmaceuticals1$13
Nabriva Therapeutics, PLC1$13
Galderma Laboratories, L.p.1$11
Strata Skin Sciences, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →